Who has invested in Highlight Therapeutics?

Columbus Life Science, Advent Life Science are named among the investors backing Highlight Therapeutics.

Highlight Therapeutics Funding: $49M Raised, Series B (2021)

Highlight Therapeutics funding overview

Highlight Therapeutics is based in Valencia, Spain. Highlight Therapeutics has raised $49M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Highlight Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Columbus Life Science, Advent Life Science. 2 distinct backers are named across the disclosed rounds.

Highlight Therapeutics at a glance

Total raised: $49M
Latest round: Series B
Latest round date: January 2021
Headquarters: Valencia, Spain
Notable investors: Columbus Life Science, Advent Life Science

Frequently asked about Highlight Therapeutics funding

How much has Highlight Therapeutics raised?: Highlight Therapeutics has raised $49M in total disclosed funding across the rounds on record.
Who has invested in Highlight Therapeutics?: Columbus Life Science, Advent Life Science are named among the investors backing Highlight Therapeutics.
What was the latest Highlight Therapeutics funding round?: The most recent disclosed round is a Series B, announced in January 2021.
Where is Highlight Therapeutics based?: Highlight Therapeutics is based in Valencia, Spain.
When did Highlight Therapeutics last raise?: The last disclosed Highlight Therapeutics round closed in January 2021 at Series B.

Highlight Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Valencia below to benchmark round size and investor mix.

Highlight Therapeutics Funding: $49M Raised, Series B (2021)

Highlight Therapeutics funding overview

Highlight Therapeutics at a glance

Frequently asked about Highlight Therapeutics funding

Companies related to Highlight Therapeutics (38)

Browse related funding lists (3)